QC
SLDB icon

Quadrature Capital’s Solid Biosciences SLDB Stock Holding History

Quadrature Capital’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$782K Buy
+78,290
New +$594K 0.01% 826
2025
Q2 		– Sell
-37,325
Closed -$138K – 1447
2025
Q1 		$138K Buy
+37,325
New +$160K ﹤0.01% 900

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Quadrature Capital's SLDB Position: Q2 2026 in Review

Quadrature Capital opened a new position in Solid Biosciences (SLDB) in Q2 2026: 78,290 shares worth $782K. The stake represents 0.01% of the portfolio and ranks #826 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in SLDB as recently as Q1 2025.

Quadrature Capital first reported a position in SLDB in Q1 2025 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Quadrature Capital held 78,290 shares of Solid Biosciences worth $782K as of Q2 2026.
  • Solid Biosciences was a new Quadrature Capital position in Q2 2026.
  • Solid Biosciences made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #826 holding.
  • Quadrature Capital first reported a position in Solid Biosciences in Q1 2025 and has held it in 2 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.